For example, treatment of DLBCL cells with the HDAC6 inhibitor ACY-1215 (Rocilinostat) was shown to activate the unfolded protein response by increasing quantity and acetylation of heat-shock proteins (HSPs), eventually resulting in cell death [18]. This evidence concerns the gene HDAC6 and diffuse large B-cell lymphoma.